Last reviewed · How we verify

NCT07140796: BFR-GVQ

Effects of Hip Blood Flow Restriction and Shockwave Therapy on Q-Angle and Plantar Pressure in Adults With Genu Varum

Not yet recruiting NA Last updated 2 September 2025
What this trial tests

NA trial testing Blood Flow Restriction Training in Genu Varum in 14 participants. Not yet recruiting.

Timeline
10 September 2025
Primary endpoint
10 September 2025
1 January 2026

Quick facts

Lead sponsorSungjin Park
PhaseNA
StatusNot yet recruiting
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingnone
Primary purposetreatment
Enrollment14
Start date10 September 2025
Primary completion10 September 2025
Estimated completion1 January 2026
Sites1 location across South Korea

Drugs / interventions tested

Conditions studied

Sponsor

Sungjin Park

Who can join

Adults 20 to 40, any sex, with Genu Varum. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to investigate the effects of gluteus medius-focused blood flow restriction (BFR) training, with or without the addition of radial shockwave therapy, on lower limb alignment in adults with genu varum. The study uses a crossover design and evaluates changes in Q-angle(Quadriceps-angle) and plantar pressure as primary outcomes. All interventions are non-invasive and supervised, and the goal is to identify effective therapeutic strategies to improve biomechanical alignment in individuals with bowed legs.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Blood Flow Restriction Training

Trials testing the same drug.

Other recruiting trials for Genu Varum

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07140796.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing